ATE218538T1 - Azahexan-derivate als substratisostere von retroviralen aspartat-proteasen - Google Patents

Azahexan-derivate als substratisostere von retroviralen aspartat-proteasen

Info

Publication number
ATE218538T1
ATE218538T1 AT96939024T AT96939024T ATE218538T1 AT E218538 T1 ATE218538 T1 AT E218538T1 AT 96939024 T AT96939024 T AT 96939024T AT 96939024 T AT96939024 T AT 96939024T AT E218538 T1 ATE218538 T1 AT E218538T1
Authority
AT
Austria
Prior art keywords
substratisosters
aspartate proteases
c4alkyl
hydrogen
retroviral aspartate
Prior art date
Application number
AT96939024T
Other languages
English (en)
Inventor
Alexander Faessler
Guido Bold
Hans-Georg Capraro
Marc Lang
Original Assignee
Novartis Erfind Verwalt Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Erfind Verwalt Gmbh filed Critical Novartis Erfind Verwalt Gmbh
Application granted granted Critical
Publication of ATE218538T1 publication Critical patent/ATE218538T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Prostheses (AREA)
  • Helmets And Other Head Coverings (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT96939024T 1995-11-21 1996-11-13 Azahexan-derivate als substratisostere von retroviralen aspartat-proteasen ATE218538T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH329695 1995-11-21
CH168696 1996-07-05
PCT/EP1996/004968 WO1997019055A1 (en) 1995-11-21 1996-11-13 Azahexane derivatives as substrate isosters of retroviral asparate proteases

Publications (1)

Publication Number Publication Date
ATE218538T1 true ATE218538T1 (de) 2002-06-15

Family

ID=25688382

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96939024T ATE218538T1 (de) 1995-11-21 1996-11-13 Azahexan-derivate als substratisostere von retroviralen aspartat-proteasen

Country Status (9)

Country Link
US (1) US6225345B1 (de)
EP (1) EP0876336B1 (de)
JP (1) JPH11514996A (de)
AT (1) ATE218538T1 (de)
AU (1) AU7623796A (de)
CA (1) CA2237016A1 (de)
DE (1) DE69621651T2 (de)
ES (1) ES2177816T3 (de)
WO (1) WO1997019055A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2959397A (en) * 1996-05-31 1998-01-05 Novartis Ag Process for the preparation of hydrazine derivatives useful as intermediates for the preparation of peptide analogues
ATE500823T1 (de) * 1998-06-23 2011-03-15 Us Of America Represented By The Secretary Dept Of Health And Human Services Arzneimittel zur behandlung von hiv-infizierten säugetieren
WO1999067254A2 (en) * 1998-06-23 1999-12-29 The United States Of America Represented By The Secretary, Department Of Health And Human Services Multi-drug resistant retroviral protease inhibitors and use thereof
ES2252257T3 (es) * 2000-06-30 2006-05-16 Elan Pharmaceuticals, Inc. Compuestos para tratar la enfermedad de alzheimer.
BR0209985A (pt) * 2001-05-22 2004-06-29 Elan Pharm Inc Composto e método para o tratamento de um paciente
US7157489B2 (en) 2002-03-12 2007-01-02 The Board Of Trustees Of The University Of Illinois HIV protease inhibitors
CA2549228C (en) 2003-12-11 2013-03-19 Abbott Laboratories Hiv protease inhibiting compounds
JP5005351B2 (ja) * 2003-12-11 2012-08-22 アボット・ラボラトリーズ Hivプロテアーゼ阻害性化合物
US7713885B2 (en) * 2005-05-11 2010-05-11 Micron Technology, Inc. Methods of etching oxide, reducing roughness, and forming capacitor constructions
EP2069303B1 (de) * 2006-07-21 2016-03-30 Gilead Sciences, Inc. Antivirale proteasehemmer
WO2011080562A1 (en) 2009-12-29 2011-07-07 Hetero Research Foundation Novel aza-peptides containing 2,2-disubstituted cyclobutyl and/or substituted alkoxy benzyl derivatives as antivirals
JOP20180009A1 (ar) 2017-02-06 2019-01-30 Gilead Sciences Inc مركبات مثبط فيروس hiv
TWI766172B (zh) 2018-07-30 2022-06-01 美商基利科學股份有限公司 抗hiv化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89900A0 (en) 1988-04-12 1989-12-15 Merck & Co Inc Hiv protease inhibitors useful for the treatment of aids and pharmaceutical compositions containing them
DE59207226D1 (de) * 1991-07-03 1996-10-31 Ciba Geigy Ag Pharmakologisch wirksame Hydrazinderivate und Verfahren zu deren Herstellung
DE59303870D1 (de) * 1992-12-23 1996-10-24 Ciba Geigy Ag Antiretrovirale hydrazinderivate
US5461067A (en) * 1993-02-25 1995-10-24 Abbott Laboratories Retroviral protease inhibiting compounds
US5538997A (en) * 1993-03-12 1996-07-23 Sandoz Ltd. 2,4-diamino-3-hydroxycarboxylic acid derivatives

Also Published As

Publication number Publication date
AU7623796A (en) 1997-06-11
CA2237016A1 (en) 1997-05-29
EP0876336A1 (de) 1998-11-11
DE69621651D1 (de) 2002-07-11
ES2177816T3 (es) 2002-12-16
DE69621651T2 (de) 2002-11-21
US6225345B1 (en) 2001-05-01
EP0876336B1 (de) 2002-06-05
WO1997019055A1 (en) 1997-05-29
JPH11514996A (ja) 1999-12-21

Similar Documents

Publication Publication Date Title
DE69332002D1 (de) Hydroxyethylaminosulfonamide verwendbar als Inhibitoren retroviraler Proteasen
CA2256582A1 (en) Oxa acids and related compounds for treating skin conditions
DE69621651D1 (de) Azahexan-derivate als substratisostere von retroviralen aspartat-proteasen
ATE136888T1 (de) Retrovirale proteaseinhibitoren
TR199900874T2 (xx) Heteroaril s�ksinamidler ve metalloproteinaz inhibit�r� olarak kullan�mlar�.
AR006720A1 (es) Un compuesto derivado de azahexano heterociclico, su uso para la preparacion de una composicion farmaceutica, procedimiento para prepararlo y una composicion farmaceutica que lo comprende
ATE228111T1 (de) M-amidinophenyl-analoga als faktor-xa-inhibitoren
ID26622A (id) Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide
DK0934080T3 (da) 1,3-Bis-(N-lactamyl)propaner og deres farmaceutiske og kosmetiske anvendelse
TR199800243T1 (xx) Prolil endopeptidaz inhibit�rleri.
NO971142L (no) Bis-(2-halogenetyl)aminofenylsubstituerte distamycinderivater som antitumor- og antivirale midler
ATE225335T1 (de) Amide derivate als 5-ht1a liganden
DE69307895D1 (de) Therapeutische verwendung von phosphoryl-l-serin-n-acyl-sphingosin
ATE206423T1 (de) Heterocyclische verbindungen zur behandlung von myokard-ischemia
DE69333270D1 (de) Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
DK0667863T3 (da) 2-Perhalogenalkyl-substituerede benzimidazoler, deres fremstilling samt deres anvendelse som pesticider
DE59310218D1 (de) Inhibitoren retroviraler proteasen
MX9601359A (es) Compuestos con radicales de (benzo)triazol.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee